Extracellular potassium modulation of drug block of IKr. Implications for torsade de pointes and reverse use-dependence

T Yang, Dan M Roden


Torsade de pointes often occurs with underlying hypokalemia and bradycardia. A common effect of many drugs producing torsade de pointes is block of the rapidly activating component of the cardiac delayed rectifier (IKr). In this study, we evaluated the effect of changing extracellular potassium ([K+]o) on IKr block by the nonspecific agent quinidine and by the specific IKr blocker dofetilide. IKr was measured in AT-1 cells, where contaminating outward currents are absent. The drug concentration producing 50% inhibition of IKr tails (IC50) was strikingly [K+]o-dependent. Elevating [K+]o from 1 to 8 mmol/L increased the IC50 for dofetilide block from 2.7 +/- 0.9 to 79 +/- 32 nmol/L and for quinidine block from 0.4 +/- 0.1 to 3.8 +/- 1.2 mumol/L. (1) The increase in drug block with low [K+]o provides a mechanism to explain the link between hypokalemia and torsade de pointes. (2) Elevations in [K+]o occur with myocardial ischemia and with rapid pacing. Possible consequences of blunted drug block with high [K+]o include loss of drug efficacy with ischemia and with rapid pacing; the latter may contribute to "reverse use-dependent" action potential prolongation. Extracellular potassium is a critical determinant of drug block of IKr, w...Continue Reading


Apr 1, 1979·Proceedings of the National Academy of Sciences of the United States of America·D C Gadsby, P F Cranefield
Feb 1, 1992·Pflügers Archiv : European journal of physiology·M C Sanguinetti, N K Jurkiewicz
Sep 1, 1988·Progress in Cardiovascular Diseases·W M JackmanR Lazzara
Aug 1, 1981·Pflügers Archiv : European journal of physiology·O P HamillF J Sigworth
Sep 1, 1994·The Journal of Physiology·H B Nuss, E Marban
Aug 1, 1993·Cardiovascular Drugs and Therapy·E Carmeliet
Mar 24, 1993·JAMA : the Journal of the American Medical Association·R L WoosleyR A Gillis

❮ Previous
Next ❯


Mar 1, 1997·Clinical Cardiology·D M Roden
Nov 24, 2004·Naunyn-Schmiedeberg's Archives of Pharmacology·Noriko SaegusaHaruaki Nakaya
Apr 18, 2007·Pflügers Archiv : European journal of physiology·Ian N SabirChristopher L-H Huang
Aug 21, 2007·Pflügers Archiv : European journal of physiology·Ian N SabirChristopher L-H Huang
Aug 25, 2012·Cardiovascular Drugs and Therapy·Oleg E Osadchii
Nov 30, 2000·Current Treatment Options in Cardiovascular Medicine·S Viskin
Apr 10, 2013·European Journal of Pharmacology·Sanmoy KarmakarTuhinadri Sen
Apr 27, 2005·Heart Rhythm : the Official Journal of the Heart Rhythm Society·Dawood DarbarAlfred L George
Mar 8, 2005·Trends in Pharmacological Sciences·Eva DelpónJuan Tamargo
Aug 7, 2002·European Journal of Pharmacology·András Farkas, Susan J Coker
Oct 3, 1999·Progress in Cardiovascular Diseases·S L Pinski, M E Helguera
Oct 24, 1998·Progress in Biophysics and Molecular Biology·E Carmeliet, K Mubagwa
Dec 1, 1996·Journal of the American College of Cardiology·C AntzelevitchG X Yan
Feb 27, 2004·Pediatric Neurology·Soonhak KwonYongkeun Cho
May 17, 2003·Journal of Pharmacological and Toxicological Methods·Andrew J Batey, Christopher P A Doe
Mar 4, 1998·British Journal of Pharmacology·A E BuschF Lang
Mar 27, 2001·British Journal of Pharmacology·T D BarrettB R Lucchesi
Feb 2, 2000·Proceedings of the Society for Experimental Biology and Medicine·R R BrooksD R Kostreva
Mar 13, 2002·Epilepsia·D M Roden
Jan 1, 1998·The New England Journal of Medicine·A A Grace, A J Camm
Mar 5, 2004·The New England Journal of Medicine·Dan M Roden
Mar 2, 2006·Toxicologic Pathology·Robert L Hamlin
Sep 21, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·C M WhiteR Quintiliani
Jun 27, 2009·Cardiovascular Research·Tamás BányászPéter P Nánási
Jun 22, 2013·Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology·Peter WeekeDan M Roden
Oct 17, 2001·Journal of Cardiovascular Pharmacology·T YangD M Roden
Feb 27, 2003·Journal of Cardiovascular Pharmacology·Michelle P McIntoshSusan J Coker
Oct 25, 2003·Journal of Cardiovascular Pharmacology·András Farkas, Michael J Curtis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiology Journals

Discover the latest cardiology research in this collection of the top cardiology journals.


Bradyarrhythmias are slow heart rates. Symptoms may include syncope, dizziness, fatigure, shortness of breath, and chest pains. Find the latest research on bradyarrhythmias here.

Anti-Arrhythmic Drug Therapies

Anti-arrhythmic drugs are used to prevent abnormal heart rhythms. These medications are used in conditions including, ventricular tachycardia, ventricular fibrillation and atrial fibrillation. Discover the latest research on anti-arrhythmic drug therapies here.

Cardiac Electrophysiology

Cardiac electrophysiology is the study of electrical activities of the heart and includes the assessment, diagnosis, and treatment of cardiac events. Find the latest research on cardiac electrophysiology here.